Recruiting
Factor VIII deficiency+1
RecruitingStudy on Long-Term Safety and Effects of Marstacimab for Patients with Severe Hemophilia A or B, With or Without Inhibitors
InvestigationalNo placebo
Study on Long-Term Safety and Effects of Marstacimab for Patients with Severe Hemophilia A or B, With or Without Inhibitors
InvestigationalNo placebo
- Disease:Factor VIII deficiencyFactor IX deficiency
- Substances:Marstacimab
Countries:
Austria
Austria- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Marstacimab




